Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for targeted cancer therapies. Its structure supports selective binding to specific enzyme active sites, enhancing drug potency and metabolic stability. Commonly employed in research settings for optimizing lead compounds in oncology and inflammatory disease programs.